Turnover: ()

Country: France

  • Producer of therapeutic cannabis
  • Global therapeutic cannabis market estimated at $30 billion by 2023
  • The global cannabis market is growing exponentially and is expected to continue to do so.
  • The French market has benefited from a very strong craze thanks to the clarification of the CBD law and the the Decree of December 30, 2021, and the Decree of February 17, 2022 authorizing the production and marketing of medical cannabis.

News

Chenevia: a start-up specializing in the production of therapeutic cannabis and premium CBD to strengthen the therapeutic arsenal against serious chronic diseases and pain. 19/03/2025

  • Chenevia, a company specializing in therapeutic cannabis and premium CBD, completes a second financing round of 3 million euros to build a 2,000 square meter factory.
  • The cost of the plant is estimated at between 2 and 3 million euros.
  • The plant, located in Meucon in the Morbihan region, will industrialize the extraction of active ingredients from cannabis and accelerate research and development (R&D) in this field.
  • Large-scale production is scheduled for early 2026
  • According to Insight Partners, the global therapeutic cannabis market is estimated to be worth over 46 billion euros by 2028.
  • Chenevia forecasts sales of between 500,000 and 1 million euros for the current year.
  • Twenty-one of Europe's twenty-seven countries have already authorized the use of medical cannabis.
  • France, although a major hemp producer, is lagging behind in this field.
  • Morocco launched its first legal cannabis crops in 2024, with revenues estimated at between 400 and 600 million euros within four years.

Studies mentioning this company

The CBD market - France

Other companies mentioned:

  • Fresh Label - Mag JAG
  • Elya - Mag Jag
  • weedy.fr
  • justbob.fr
  • Lafermeducbd.fr
  • CBD eau
  • Le Lab Paris
  • Green House CBD Shop
  • Green Leaf HelloJoya
  • Naturellement chanvre
  • Tilray Brands
  • Le Chanvrier Français
  • Hemp It
  • Overseed
  • Chenevia Pharma